API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
0
Other Suppliers
USA (Orange Book)
0
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
11
PharmaCompass offers a list of Fenbendazole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fenbendazole manufacturer or Fenbendazole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fenbendazole manufacturer or Fenbendazole supplier.
PharmaCompass also assists you with knowing the Fenbendazole API Price utilized in the formulation of products. Fenbendazole API Price is not always fixed or binding as the Fenbendazole Price is obtained through a variety of data sources. The Fenbendazole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Oxfendazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxfendazole, including repackagers and relabelers. The FDA regulates Oxfendazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxfendazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Oxfendazole manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Oxfendazole supplier is an individual or a company that provides Oxfendazole active pharmaceutical ingredient (API) or Oxfendazole finished formulations upon request. The Oxfendazole suppliers may include Oxfendazole API manufacturers, exporters, distributors and traders.
click here to find a list of Oxfendazole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Oxfendazole DMF (Drug Master File) is a document detailing the whole manufacturing process of Oxfendazole active pharmaceutical ingredient (API) in detail. Different forms of Oxfendazole DMFs exist exist since differing nations have different regulations, such as Oxfendazole USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Oxfendazole DMF submitted to regulatory agencies in the US is known as a USDMF. Oxfendazole USDMF includes data on Oxfendazole's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Oxfendazole USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Oxfendazole suppliers with USDMF on PharmaCompass.
A Oxfendazole CEP of the European Pharmacopoeia monograph is often referred to as a Oxfendazole Certificate of Suitability (COS). The purpose of a Oxfendazole CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Oxfendazole EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Oxfendazole to their clients by showing that a Oxfendazole CEP has been issued for it. The manufacturer submits a Oxfendazole CEP (COS) as part of the market authorization procedure, and it takes on the role of a Oxfendazole CEP holder for the record. Additionally, the data presented in the Oxfendazole CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Oxfendazole DMF.
A Oxfendazole CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Oxfendazole CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Oxfendazole suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Oxfendazole as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Oxfendazole API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Oxfendazole as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Oxfendazole and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Oxfendazole NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Oxfendazole suppliers with NDC on PharmaCompass.
Oxfendazole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oxfendazole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oxfendazole GMP manufacturer or Oxfendazole GMP API supplier for your needs.
A Oxfendazole CoA (Certificate of Analysis) is a formal document that attests to Oxfendazole's compliance with Oxfendazole specifications and serves as a tool for batch-level quality control.
Oxfendazole CoA mostly includes findings from lab analyses of a specific batch. For each Oxfendazole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oxfendazole may be tested according to a variety of international standards, such as European Pharmacopoeia (Oxfendazole EP), Oxfendazole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oxfendazole USP).